1.06
0.23 (26.99%)
| Penutupan Terdahulu | 0.835 |
| Buka | 0.889 |
| Jumlah Dagangan | 4,769,751 |
| Purata Dagangan (3B) | 1,143,978 |
| Modal Pasaran | 114,062,752 |
| Harga / Buku (P/B) | 1.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Nov 2025 |
| EPS Cair (TTM) | -0.290 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 15.40% |
| Nisbah Semasa (MRQ) | 3.20 |
| Aliran Tunai Operasi (OCF TTM) | -26.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -15.09 M |
| Pulangan Atas Aset (ROA TTM) | -76.34% |
| Pulangan Atas Ekuiti (ROE TTM) | -213.85% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Oncolytics Biotech Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -0.88 |
|
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.92% |
| % Dimiliki oleh Institusi | 1.53% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Seeds Investor Llc | 31 Dec 2025 | 258,306 |
| Headinvest, Llc | 31 Dec 2025 | 44,700 |
| Badgley Phelps Wealth Managers, Llc | 31 Dec 2025 | 40,000 |
| Ball & Co Wealth Management Inc. | 31 Dec 2025 | 38,253 |
| Julat 52 Minggu | ||
| Median | 10.00 (843.40%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 17 Nov 2025 | 10.00 (843.40%) | Beli | 1.05 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |